Challenger Total Current Liabilities vs Other Current Liab Analysis

CGF Stock

5.89 0.09 1.51%

Challenger financial indicator trend analysis is way more than just evaluating Challenger prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Challenger is a good investment. Please check the relationship between Challenger Total Current Liabilities and its Other Current Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Challenger. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Total Current Liabilities vs Other Current Liab

Total Current Liabilities vs Other Current Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Challenger Total Current Liabilities account and Other Current Liab. At this time, the significance of the direction appears to have strong relationship.

The correlation between Challenger's Total Current Liabilities and Other Current Liab is 0.74. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Other Current Liab in the same time period over historical financial statements of Challenger, assuming nothing else is changed. The correlation between historical values of Challenger's Total Current Liabilities and Other Current Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Challenger are associated (or correlated) with its Other Current Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Liab has no effect on the direction of Total Current Liabilities i.e., Challenger's Total Current Liabilities and Other Current Liab go up and down completely randomly.

Correlation Coefficient

0.74

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Total Current Liabilities

Total Current Liabilities is an item on Challenger balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Challenger are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Other Current Liab

Most indicators from Challenger's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Challenger current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Challenger. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Challenger's Selling General Administrative is comparatively stable compared to the past year. Tax Provision is likely to gain to about 68 M in 2024, whereas Discontinued Operations is likely to drop (7.6 M) in 2024.

	2021	2022	2023	2024 (projected)
Other Operating Expenses	233.9M	1.1B	635.9M	604.1M
Gross Profit	1.4B	652.2M	635.9M	989.5M

Other Operating Expenses Gross Profit

Challenger fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Accounts Payable	Cash	Long Term Debt	Short Term Investments	Total Liab	Common Stock	Retained Earnings	Other Assets	Other Liab	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Property Plant And Equipment Net	Net Debt	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Property Plant And Equipment Gross	Total Current Assets
Total Assets		0.96	0.72	0.34	0.34	0.62	0.62	0.98	0.85	-0.06	0.77	0.79	0.7	0.86	-0.14	0.81	0.54	0.57	-0.33	-0.2	0.83	0.88	0.58	0.52	-0.03	0.12
Total Stockholder Equity	0.96		0.67	0.17	0.29	0.6	0.52	0.97	0.95	0.07	0.7	0.78	0.67	0.89	-0.19	0.66	0.47	0.52	-0.48	-0.39	0.8	0.9	0.67	0.38	-0.08	-0.05
Accounts Payable	0.72	0.67		0.12	0.3	0.44	0.45	0.72	0.56	-0.12	0.64	0.8	0.51	0.79	-0.38	0.7	0.56	0.62	-0.51	-0.41	0.51	0.72	0.48	0.36	-0.35	0.15
Cash	0.34	0.17	0.12		0.49	0.02	0.25	0.26	0.09	0.01	0.19	0.3	0.16	-0.08	0.45	0.49	0.04	-0.01	0.62	0.66	0.48	0.01	0.14	0.34	0.46	0.17
Long Term Debt	0.34	0.29	0.3	0.49		-0.4	-0.08	0.31	0.29	0.62	-0.09	0.62	-0.26	0.06	0.38	0.48	-0.32	-0.33	0.2	0.13	0.64	0.1	-0.06	-0.1	0.34	-0.49
Short Term Investments	0.62	0.6	0.44	0.02	-0.4		0.63	0.62	0.47	-0.63	0.91	0.31	0.95	0.7	-0.45	0.44	0.81	0.85	-0.4	-0.17	0.21	0.66	0.62	0.59	-0.33	0.59
Total Liab	0.62	0.52	0.45	0.25	-0.08	0.63		0.62	0.27	-0.61	0.57	0.29	0.76	0.62	-0.35	0.4	0.89	0.83	0.05	0.18	0.34	0.65	0.53	0.98	-0.22	0.35
Common Stock	0.98	0.97	0.72	0.26	0.31	0.62	0.62		0.85	-0.03	0.74	0.8	0.7	0.89	-0.19	0.76	0.56	0.61	-0.41	-0.3	0.8	0.93	0.63	0.5	-0.08	0.05
Retained Earnings	0.85	0.95	0.56	0.09	0.29	0.47	0.27	0.85		0.26	0.57	0.71	0.53	0.78	-0.09	0.53	0.25	0.3	-0.54	-0.48	0.78	0.75	0.61	0.13	0.01	-0.18
Other Assets	-0.06	0.07	-0.12	0.01	0.62	-0.63	-0.61	-0.03	0.26		-0.52	0.29	-0.58	-0.18	0.36	-0.1	-0.74	-0.71	-0.09	-0.26	0.34	-0.17	-0.13	-0.68	0.28	-0.88
Other Liab	0.77	0.7	0.64	0.19	-0.09	0.91	0.57	0.74	0.57	-0.52		0.5	0.86	0.72	-0.27	0.71	0.73	0.78	-0.4	-0.16	0.43	0.7	0.52	0.54	-0.16	0.62
Short Long Term Debt Total	0.79	0.78	0.8	0.3	0.62	0.31	0.29	0.8	0.71	0.29	0.5		0.4	0.71	-0.12	0.77	0.29	0.34	-0.38	-0.31	0.77	0.68	0.45	0.19	-0.1	-0.2
Other Current Liab	0.7	0.67	0.51	0.16	-0.26	0.95	0.76	0.7	0.53	-0.58	0.86	0.4		0.74	-0.42	0.45	0.87	0.89	-0.29	-0.08	0.33	0.7	0.76	0.73	-0.29	0.48
Total Current Liabilities	0.86	0.89	0.79	-0.08	0.06	0.7	0.62	0.89	0.78	-0.18	0.72	0.71	0.74		-0.54	0.56	0.68	0.74	-0.62	-0.53	0.52	0.97	0.68	0.47	-0.43	0.1
Property Plant And Equipment Net	-0.14	-0.19	-0.38	0.45	0.38	-0.45	-0.35	-0.19	-0.09	0.36	-0.27	-0.12	-0.42	-0.54		0.07	-0.52	-0.56	0.42	0.4	0.32	-0.47	-0.5	-0.27	0.98	-0.14
Net Debt	0.81	0.66	0.7	0.49	0.48	0.44	0.4	0.76	0.53	-0.1	0.71	0.77	0.45	0.56	0.07		0.37	0.4	-0.14	0.04	0.74	0.59	0.18	0.38	0.12	0.32
Non Current Assets Total	0.54	0.47	0.56	0.04	-0.32	0.81	0.89	0.56	0.25	-0.74	0.73	0.29	0.87	0.68	-0.52	0.37		0.98	-0.25	-0.06	0.15	0.65	0.6	0.86	-0.42	0.51
Non Currrent Assets Other	0.57	0.52	0.62	-0.01	-0.33	0.85	0.83	0.61	0.3	-0.71	0.78	0.34	0.89	0.74	-0.56	0.4	0.98		-0.37	-0.19	0.15	0.7	0.61	0.79	-0.46	0.51
Cash And Short Term Investments	-0.33	-0.48	-0.51	0.62	0.2	-0.4	0.05	-0.41	-0.54	-0.09	-0.4	-0.38	-0.29	-0.62	0.42	-0.14	-0.25	-0.37		0.95	-0.13	-0.53	-0.33	0.21	0.4	0.09
Net Receivables	-0.2	-0.39	-0.41	0.66	0.13	-0.17	0.18	-0.3	-0.48	-0.26	-0.16	-0.31	-0.08	-0.53	0.4	0.04	-0.06	-0.19	0.95		-0.05	-0.45	-0.25	0.35	0.39	0.3
Good Will	0.83	0.8	0.51	0.48	0.64	0.21	0.34	0.8	0.78	0.34	0.43	0.77	0.33	0.52	0.32	0.74	0.15	0.15	-0.13	-0.05		0.54	0.32	0.26	0.39	-0.22
Common Stock Total Equity	0.88	0.9	0.72	0.01	0.1	0.66	0.65	0.93	0.75	-0.17	0.7	0.68	0.7	0.97	-0.47	0.59	0.65	0.7	-0.53	-0.45	0.54		0.66	0.51	-0.36	0.1
Common Stock Shares Outstanding	0.58	0.67	0.48	0.14	-0.06	0.62	0.53	0.63	0.61	-0.13	0.52	0.45	0.76	0.68	-0.5	0.18	0.6	0.61	-0.33	-0.25	0.32	0.66		0.45	-0.42	-0.02
Non Current Liabilities Total	0.52	0.38	0.36	0.34	-0.1	0.59	0.98	0.5	0.13	-0.68	0.54	0.19	0.73	0.47	-0.27	0.38	0.86	0.79	0.21	0.35	0.26	0.51	0.45		-0.16	0.45
Property Plant And Equipment Gross	-0.03	-0.08	-0.35	0.46	0.34	-0.33	-0.22	-0.08	0.01	0.28	-0.16	-0.1	-0.29	-0.43	0.98	0.12	-0.42	-0.46	0.4	0.39	0.39	-0.36	-0.42	-0.16		-0.08
Total Current Assets	0.12	-0.05	0.15	0.17	-0.49	0.59	0.35	0.05	-0.18	-0.88	0.62	-0.2	0.48	0.1	-0.14	0.32	0.51	0.51	0.09	0.3	-0.22	0.1	-0.02	0.45	-0.08

Click cells to compare fundamentals

Challenger Account Relationship Matchups

Challenger fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	28.6B	30.0B	29.7B	31.0B	33.4B	21.2B
Total Stockholder Equity	3.2B	3.8B	4.0B	4.2B	3.9B	2.4B
Accounts Payable	1.6B	1.7B	726.2M	854.6M	1.2B	1.2B
Cash	661.9M	989.4M	733.1M	593.4M	573.2M	855.6M
Long Term Debt	7.7B	6.3B	1.6B	5.8B	1.5B	1.4B
Short Term Investments	8.3B	11.9B	26.3B	27.6B	30.0B	31.5B
Total Liab	25.3B	26.2B	25.7B	26.8B	29.5B	15.0B
Common Stock	2.4B	2.5B	2.5B	2.5B	2.6B	1.7B
Retained Earnings	922.9M	1.5B	1.6B	1.7B	1.4B	729.1M
Other Assets	4.5B	4.0B	4.2B	86.3M	(30.9B)	(29.3B)
Other Liab	13.6B	14.5B	14.6B	20.7B	23.8B	25.0B
Short Long Term Debt Total	13.4B	10.8B	10.0B	10.4B	7.1B	8.4B
Other Current Liab	1.6B	3.1B	4.1B	4.3B	3.8B	4.0B
Total Current Liabilities	8.8B	9.3B	9.1B	9.6B	10.6B	5.5B
Property Plant And Equipment Net	58.3M	62.9M	53.8M	47.8M	39.3M	72.4M
Net Debt	7.1B	5.4B	5.1B	5.3B	6.6B	6.4B
Non Current Assets Total	27.3B	27.8B	28.3B	29.4B	31.8B	33.4B
Non Currrent Assets Other	24.3B	25.2B	25.1B	26.2B	31.1B	32.7B
Cash And Short Term Investments	661.9M	989.4M	733.1M	593.4M	573.2M	544.5M
Net Receivables	731.8M	913.4M	1.2B	1.1B	1.2B	1.9B
Liabilities And Stockholders Equity	28.6B	30.0B	29.7B	31.0B	33.4B	24.8B
Non Current Liabilities Total	16.5B	16.9B	16.7B	17.2B	18.9B	13.4B
Property Plant And Equipment Gross	28.6M	58.3M	73.6M	70.3M	67.9M	75.3M
Total Current Assets	1.3B	2.2B	1.4B	1.5B	32.5B	34.1B
Short Term Debt	5.6B	4.4B	4.2B	4.5B	5.6B	4.0B
Intangible Assets	598M	589.1M	587.2M	587.4M	4.8M	4.6M
Property Plant Equipment	58.3M	62.9M	53.8M	47.8M	55.0M	98.6M
Current Deferred Revenue	1M	48.1M	66.5M	1.0	7.4M	7.8M
Inventory	(1.4B)	(1.9B)	(1.9B)	(1.7B)	(31.7B)	(30.2B)
Other Current Assets	1.3B	2.2B	1.4B	1.5B	721.9M	1.0B
Treasury Stock	(96.8M)	(61.6M)	(47.1M)	(36.9M)	(42.4M)	(44.6M)
Other Stockholder Equity	(47.1M)	(36.9M)	(24M)	(30.4M)	(53.8M)	(56.5M)
Net Tangible Assets	2.7B	3.2B	3.4B	3.6B	4.1B	2.9B
Long Term Investments	12.6B	10.3B	74.9M	81.9M	86.6M	82.3M
Short Long Term Debt	5.6B	4.4B	4.2B	4.5B	5.6B	4.7B
Long Term Debt Total	7.8B	6.4B	5.8B	5.9B	5.3B	5.2B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Challenger Stock Analysis

When running Challenger's price analysis, check to measure Challenger's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Challenger is operating at the current time. Most of Challenger's value examination focuses on studying past and present price action to predict the probability of Challenger's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Challenger's price. Additionally, you may evaluate how the addition of Challenger to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC